US 10851367
Tissue-specific genome engineering using CRISPR-Cas9
granted A61KA61K47/545A61K47/549
Quick answer
US patent 10851367 (Tissue-specific genome engineering using CRISPR-Cas9) held by The Regents of the University of California expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/545, A61K47/549, A61P, A61P1/16